Article
Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation.
British journal of pharmacology - 1 Jul 2009
Hoffmann L S, Schmidt P M, Keim Y, Schaefer S, Schmidt H H H W, Stasch J P
Abstract excerpt
BACKGROUND AND PURPOSE: In endothelial dysfunction, signalling by nitric oxide (NO) is impaired because of the oxidation and subsequent loss of the soluble guanylyl cyclase (sGC) haem. The sGC activator 4-[((4-carboxybutyl){2-[(4-phenethylbenzyl)oxy]phenethyl}amino)methyl[benzoic]acid (BAY 58-2667) is a haem-mimetic able to bind with high affinity to sGC when the native haem (the NO binding site) is removed and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
